Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and efficacy of AGN-214868 in patients with postherpetic neuralgia (PHN) - nerve pain.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT00394901 · Neuralgia, Postherpetic
NCT00282763 · Neuralgia, Postherpetic
NCT00245544 · Neuralgia, Postherpetic
NCT00570310 · Neuralgia, Postherpetic, Diabetic Neuropathy, and more
NCT00160511 · Neuralgia, Postherpetic
Orlando, Florida
Brno
Kiel, Kiel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions